Filana Therapeutics, Inc. · NASDAQ:FLNA
Filana Therapeutics, Inc. shareholders
As of Sep 30, 2026, 76 institutions reported holding Filana Therapeutics, Inc., 19.9% of its shares. Largest: Vanguard, BlackRock and Marshall Wace, LLP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Filana Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 2.41M | 5.0% | −45,261 | Nov 16, 2026 |
| BlackRock | 1.45M | 3.0% | −6,846 | Nov 13, 2026 |
| Marshall Wace, LLP | 1.16M | 2.4% | −436K | Nov 13, 2026 |
| Geode Capital | 612K | 1.3% | −3,315 | Nov 6, 2026 |
| GMT Capital Corp | 450K | 0.93% | no change | Nov 16, 2026 |
| Gsa Capital Partners LLP | 436K | 0.90% | +166K | Nov 16, 2026 |
| Two Sigma | 423K | 0.88% | −1.29M | Nov 16, 2026 |
| Squarepoint Ops LLC | 376K | 0.78% | +57,612 | Nov 9, 2026 |
| Acadian Asset Management LLC | 317K | 0.66% | +22,118 | Nov 9, 2026 |
| Renaissance Technologies | 222K | 0.46% | −167K | Nov 12, 2026 |